Whitfield Theodore K Jr

Avg. Two Year Performance

No purchase track record

(3%) Avg. Sale Return

(1%) Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	4%	4%	10%	(2%)	(3%)
Sale Success Rate	3 of 6	2 of 6	3 of 6	1 of 6	0 of 6

Chattem Inc.

Drugs » Drug Manufacturers - Other

VP and General Counsel:

Holdings: 0 shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--